← SynDRA
SCH-58261
SynDRA canonical compound SYN0000985 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ADORA2A |
|---|
| Mechanism of action | Adenosine receptor antagonist |
|---|
All known targets
- ADORA2A
- ADORA1
- ADORA2B
- ADORA3
- GRM1
Mechanisms of action (all sources)
- Adenosine receptor antagonist
- ADORA1 ANTAGONIST
- ADORA2A ANTAGONIST
- ADORA2B ANTAGONIST
- ADORA3 ANTAGONIST
- GRM1 ANTAGONIST
Cross-references
Synonyms
- PF-1913539
- Sch 58261
- Sch58261
- 2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine
- UNII-4309023MAH
- CHEMBL17127
- 4309023MAH
- 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine
- 2-(2-Furanyl)-7-(2-phenylethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine
- 5-Amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo(4,3-e)-1,2,4-triazolo(1,5-c)pyrimidine
- [3H]SCH 58261
- RefChem:884671
- DTXCID8089290
- MFCD00933778
- C18H15N7O
- GTPL403
- GTPL431
- SCHEMBL537287
- orb1300293
- CHEBI:93424
- GLXC-06761
- HMS3263L20
- HMS3268F20
- HMS3413A10
- HMS3677A10
- HMS3748I07
- HMS3886N04
- EX-A1464
- Tox21_501259
- BDBM50048466
- PDSP1_001199
- PDSP2_001183
- s8104
- SCH58261?
- SP-341
- AKOS022181216
- [3H]-SCH 58261
- CCG-222563
Look up SCH-58261 in the interactive SynDRA portal →